Aubin Fleiss

MRC London Institute of Medical Sciences

Papers

1

Total Citations

6

H-Index

1

About

Aubin Fleiss is a synthetic biologist and bioengineer whose work sits at the intersection of open-source hardware, automation, and pandemic-response diagnostics. He is best known as the lead author of the landmark 2020 paper introducing CONTAIN—an open-source, shipping container-based laboratory designed for high-throughput, automated COVID-19 diagnostics. This work, which has garnered 6 citations, represents a pioneering effort to address the logistical and industrial-scale challenges of population-wide screening during a global health crisis. By reimagining the laboratory as a modular, deployable unit, Fleiss demonstrated how synthetic biology and engineering principles can be harnessed to build resilient, decentralised diagnostic infrastructure. His contributions extend beyond the bench: CONTAIN embodies a philosophy of open science and reproducibility, offering a blueprint for future pandemic preparedness. Fleiss’s research bridges molecular diagnostics, automation, and hardware design, positioning him as a key figure in the movement to democratise access to advanced biotechnologies. His work continues to inspire students and researchers interested in the practical, scalable application of synthetic biology to real-world problems.

Research Focus

Key Achievements

1
H-Index
1
Papers
6
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
CONTAIN: An open-source shipping container laboratory optimised for automated COVID-19 diagnostics
6 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 15
🏛 Institutions: MRC London Institute of Medical Sciences

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago